RIDA®Jump
The Ultimate Platform for High-Throughput Multiplex PCR Processing
The RIDA®Jump is a high-throughput Multiplex Tandem PCR (MT-PCR) platform designed to automate complex molecular diagnostic workflows while delivering fast, reliable and reproducible results. Capable of processing up to 96 samples per run, the system combines intelligent automation, precise liquid handling and streamlined assay preparation to reduce hands-on time and maximise laboratory productivity. With approximately 10 minutes of hands-on setup and results available in around 3 hours, the RIDA®Jump provides an efficient solution for laboratories managing routine and high-demand molecular testing.
Features & Benefits
- Test up to 96 samples per run
- Automation of MT-PCR allows detection of up to 40 gene targets simultaneously
- Streamlined efficiency – up to 3 RIDA®Plex panels prepared concurrently
- Faster processing with 8-channel pipettor head
- Samples per annum – 36,000 – 72,000
High-Throughput MT-PCR Processing
The RIDA®Jump has been developed for laboratories that require rapid, large-scale molecular testing without compromising accuracy or consistency. Its automated MT-PCR workflow supports the simultaneous detection of multiple genetic targets from a single sample, enabling comprehensive syndromic testing while reducing manual processing steps. With the capacity to process up to 96 samples per run and prepare up to 3 RIDA®Plex panels concurrently, the platform helps laboratories increase throughput, improve turnaround times and maintain efficient daily operations.
Streamlined Efficiency
The RIDA®Jump has been engineered to optimise laboratory workflows through intelligent automation and simultaneous processing capabilities. Microplates and test components can be prepared in parallel, reducing bottlenecks and ensuring efficient use of laboratory resources. Automated error checking verifies reagent selection and placement before each run, while the integrated barcode scanner records primary sample tube barcodes and reagent information automatically. This seamless traceability strengthens workflow reliability, supports quality assurance and minimises the risk of manual handling errors.
High Precision Liquid Handling
At the core of the RIDA®Jump is a high-performance 8-channel pipetting system designed to deliver accurate and reproducible liquid handling across every run. Advanced pressure monitoring and rapid liquid level detection safeguard dispensing precision, while air displacement non-contact dispensing eliminates the need for system liquids, reducing maintenance requirements and simplifying operation. Easily replaceable inline filters provide additional protection by preventing liquid from entering the pipetting head, helping maintain operational security and consistent assay performance.
| Dimensions | 145 W x 78 D x 87 H cm |
| Weight | 130kg (approx.) |
| Processing Capacity | 1 – 96 Samples per Run |
| Throughput / 8hr Shift | Up to 384 Samples |
| Total Processing Time | 3 hrs |
| Volume Range | 0.5 – 5000μl |
| Protocols | Preinstalled |
| Power Supply | 110 – 240V, 50/60Hz |
| Regulatory Compliance | Compliant to Directives 2014/35/EU, 2014/30/EU, CSA Compliant |
High-Throughput Automation for Modern Molecular Diagnostics
The RIDA®Jump provides laboratories with a scalable MT-PCR platform that combines high-throughput processing, intelligent automation and precise liquid handling in a single integrated system. Designed to support routine and high-demand molecular testing, it delivers reliable multiplex PCR performance while reducing hands-on time and improving workflow consistency. Supported by R-Biopharm Australia’s local expertise, the RIDA®Jump enables laboratories to confidently manage growing testing volumes while maintaining the accuracy, traceability and reproducibility required for modern molecular diagnostics.
Systems are intended for in vitro diagnostics use by authorised clinical testing laboratories in Australia, New Zealand, Great Britain, and the European Economic Area, and are included on the Australian Register of Therapeutic Goods (ARTG), the MHRA database (REF: 10541) and compliant with the European Regulation (EU) 2017/746 . In the USA: For Research Use Only (RUO), not for use In diagnostic procedures.
